GEFISTERIS 250 & Gefitinib (250mg): Uses, Dosage, Side Effects,Composition , ETC......

GEFISTERIS 250

Gefitinib (250mg)

GEFISTERIS 250, containing the active ingredient Gefitinib 250mg, is primarily used in the treatment of non-small cell lung cancer (NSCLC). It targets specific cancer cell growth factors and is particularly effective in patients who have certain types of genetic mutations.

Composition

• Active Ingredient: Gefitinib (250mg per tablet).
• Inactive Ingredients: Lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone, among others.

Uses

• Primary Use: Management of locally advanced or metastatic non-small cell lung cancer, especially in patients with EGFR mutations.
• Mechanism of Action: Gefitinib inhibits the tyrosine kinase activity associated with the epidermal growth factor receptor (EGFR), which is found to be overexpressed in many NSCLC tumors.

Dosage

• Standard Dosage: One 250mg tablet taken orally once daily.
• Administration Advice: Can be taken with or without food. However, consistency in taking it relative to meals is recommended to maintain stable blood levels.

Side Effects

• Common Side Effects: Diarrhea, rash, acne, dry skin, nausea, and vomiting.
• Serious Side Effects: Interstitial lung disease, severe liver toxicity, and gastrointestinal perforation.
• Precautions: Regular monitoring of liver function and lung symptoms is recommended during treatment.

Price

• Cost Factors: The price can vary widely based on insurance coverage, geographic location, and pharmacy.
• Insurance: Often covered under cancer treatment plans, but patients should verify specifics with their insurer.

General Advice

• Before Starting GEFISTERIS 250: Patients should discuss potential interactions with other medication and confirm the presence of EGFR mutations for optimal effectiveness.
• Monitoring and Consultation: It’s crucial to maintain regular check-ups to monitor the drug's effectiveness and side effects.

Conclusion GEFISTERIS 250 offers a targeted approach to treating non-small cell lung cancer, making it a vital component of cancer therapy for patients with specific genetic profiles. Ensuring proper usage and monitoring can significantly enhance treatment outcomes.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW